Bioabsorbable Stent Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The bioabsorbable stent market encompasses coronary and peripheral vascular scaffolds made from biodegradable materials such as magnesium alloys and polymers, which gradually dissolve after fulfilling their function. With a 2025 valuation near $15.39 billion and projected expansion toward a combined stent market of $18.46 billion by 2030 at a 3.7% CAGR, the sector represents a significant portion of the broader cardiovascular devices industry.

• •Over 2 million stent placements are performed globally each year, providing a large addressable patient population
• •Bioabsorbable scaffolds are engineered from magnesium-based and polymer-based materials that naturally absorb into the body
• •Market size estimates are derived from commercial market intelligence, though bioabsorbable stent revenues are not always separated from broader stent categories in standard government statistical reporting

Rising global cardiovascular disease incidence and mortality rates are the primary catalysts for bioabsorbable stent adoption, as more patients require interventional procedures to restore blood flow. The clinical advantage of avoiding permanent foreign objects in coronary arteries, reducing late stent thrombosis risk and enabling natural vessel restoration, has generated strong physician and patient interest.

• •Aging populations in developed and emerging markets are increasing the prevalence of coronary artery disease requiring percutaneous coronary intervention
• •Clinical evidence supporting magnesium- and polymer-based bioresorbable scaffolds has expanded, leading to broader adoption by 2030
• •Government-supported registries such as the National Cardiovascular Data Registry CathPCI Registry provide official U.S. procedure volumes that inform market projections

The market is segmented by product type, including bioresorbable vascular scaffolds, fully absorbable stent systems, and drug-eluting absorbable platforms. Geographically, North America and Europe represent mature markets with established regulatory pathways, while the Asia-Pacific region offers rapid growth potential due to improving healthcare infrastructure and rising disease burden.

• •Product categories include magnesium alloy-based scaffolds, polymer-based scaffolds, and drug-eluting bioabsorbable designs
• •Regulatory clearance records published by government agencies confirm ongoing product approvals in major markets
• •Medical-grade polymer industry frameworks identify bioresorbable stent growth vectors through 2025 and beyond

What are the recent trends and outlook?

Future development is directed toward improving biocompatibility, shortening absorption timelines, and integrating drug-eluting capabilities into fully absorbable platforms. The convergence of regenerative medicine principles with vascular stent design is anticipated to yield next-generation implants with enhanced healing profiles. From 2025 to 2030, the market is expected to sustain its 3.7% growth trajectory supported by ongoing clinical research, incremental regulatory clearances, and expanding adoption in lower-limb arterial disease applications.

• •Research into biodegradable metallic biomaterials is advancing, with projections indicating robust growth in implantable and biodegradable technology segments
• •Regenerative medicine approaches are being applied to vascular stent development, with an emphasis on promoting natural vessel healing
• •Clinical performance data and real-world evidence are expanding the use cases for bioresorbable scaffolds beyond coronary applications into peripheral arterial disease